
Mabwell’s investigational 9MW3811 is the first IL-11–targeting therapy to enter clinical evaluation for pathological scarring.

Mabwell’s investigational 9MW3811 is the first IL-11–targeting therapy to enter clinical evaluation for pathological scarring.

Explore the latest insights on hyperhidrosis, its impact on quality of life, and advancements in effective treatment options for this often-overlooked condition.

Discover essential dermatology awareness dates and initiatives for 2026, as we enhance patient care with updates, interviews, and resources throughout the year.

Explore top dermatology conferences and meetings in January 2026 and let us know which ones you'll be attending!

Share your thoughts and help shape our content by telling us what topics you want to see more of this year.

Discover the top dermatology conferences and meetings for 2026, and share your insights on upcoming events in the field.

Explore the latest advancements in dermatology for 2026, featuring innovative therapies and treatments for skin conditions, hair loss, and more.

Explore the top headlines of 2025, including insights on the latest clinical trials, therapeutic updates, and more.

Innovative approaches in 2025 have enhanced skin health equity by improving global access to dermatology trials, ensuring diverse representation, and community engagement.

Explore the complexities of shampoo types, from dry to dandruff solutions, and discover the best options for your unique hair needs.

Explore key insights and highlights from the major dermatology conferences Dermatology Times attended in 2025, featuring expert speakers and innovative clinical practice tips.

Discover groundbreaking FDA dermatology approvals in 2025, featuring innovative therapies for chronic skin conditions and pediatric care advancements.

Explore essential best practices for dermatologists pursuing entrepreneurial ventures and side hustles to enhance income and professional growth.

Dermatology evolves in 2025, focusing on personalized care, safety, and technology integration, while addressing systemic health and patient outcomes.

Aesthetic dermatology in 2025 emphasizes innovation, safety, and natural results, reshaping patient care with personalized treatment plans and advanced technologies.

Discover the 2025 advancements in AD treatment, including new therapies, pediatric approvals, and insights into effective management strategies.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Discover the latest advancements in psoriasis treatment, including innovative therapies and personalized care options for improved patient outcomes in 2025.

CHE has gained attention in 2025 with an FDA-approved treatment and new insights, addressing its significant impact on patients' lives and work.

Discover key insights from the 2025 Fall Clinical Dermatology Conference, featuring advancements in eczema, skin cancer testing, and pediatric psoriasis therapies.

As 2025 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in rosacea this year.

The Society of Dermatology Physician Assistants (SDPA) 23rd Annual Fall Dermatology Conference highlights mentorship, leadership, and innovative education, shaping the future of dermatology and enhancing patient care.

As 2025 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in acne this year.

Read on to catch up on all of the episodes of Derm Dispatch from this year.

Discover the latest advancements in CSU treatment, including new therapies and evolving management strategies for better patient outcomes.

Spizuoco leads the inaugural DermVIP Summit, enhancing alopecia education for dermatology professionals through expert insights and innovative treatments.

Pediatric dermatology experiences a transformative shift, enhancing care for younger patients and expanding therapeutic options.

John Barbieri, MD, MBA; Ted Rosen, MD; Peter Lio, MD; Shanna Miranti, MPAS, PA-C; and Larissa Schmidt, DPM, share what gifts they would give to the field of dermatology this holiday season.

As 2025 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Brad Glick, DO, MPH, and attendees discuss innovative treatments for atopic dermatitis, emphasizing the importance of patient comfort and modern nonsteroidal options.